Immunotherapy & Oncology
Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.
388 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 1 |
BlackRock
New York
| $198B | +$533M | 209 | 3.45% | Increased |
|
| 2 |
Vanguard Capital Management
Malvern,
Pennsylvania
| $149B | +$146B | 198 | 3.67% | New |
|
| 3 |
State Street
Boston,
Massachusetts
| $110B | -$285M | 181 | 3.8% | Reduced |
|
| 4 |
Vanguard Portfolio Management
Malvern,
Pennsylvania
| $59.4B | +$58.5B | 105 | 3.1% | New |
|
| 5 |
JP Morgan Chase
New York
| $58.4B | +$13B | 178 | 3.75% | Increased |
|
| 6 |
Geode Capital Management
Boston,
Massachusetts
| $55.3B | +$1.29B | 226 | 3.44% | Increased |
|
| 7 |
Fidelity Investments
Boston,
Massachusetts
| $51.1B | +$6.69B | 157 | 2.69% | Increased |
|
| 8 |
Morgan Stanley
New York
| $46.4B | -$417M | 233 | 2.8% | Reduced |
|
| 9 |
Capital World Investors
Los Angeles,
California
| $31.3B | +$9.18B | 16 | 4.27% | Increased |
|
| 10 |
Wellington Management Group
Boston,
Massachusetts
| $31.2B | +$346M | 73 | 5.83% | Increased |
|
| 11 |
Bank of America
Charlotte,
North Carolina
| $31B | +$696M | 150 | 2.26% | Increased |
|
| 12 |
Invesco
Atlanta,
Georgia
| $28.2B | +$163M | 112 | 2.76% | Increased |
|
| 13 |
T. Rowe Price Associates
Baltimore,
Maryland
| $26.8B | +$1.78B | 109 | 3.1% | Increased |
|
| 14 |
Charles Schwab
San Francisco,
California
| $26.7B | -$2.8B | 118 | 4.09% | Reduced |
|
| 15 |
Northern Trust
Chicago,
Illinois
| $25.9B | -$134M | 178 | 3.42% | Reduced |
|
| 16 |
Goldman Sachs
New York
| $23.2B | +$2.96B | 151 | 2.67% | Increased |
|
| 17 |
Legal & General Group
London,
United Kingdom
| $20.9B | +$5.08B | 103 | 4.84% | Increased |
|
| 18 |
Bank of New York Mellon
New York
| $20.1B | +$533M | 113 | 3.7% | Increased |
|
| 19 |
Franklin Resources
San Mateo,
California
| $18.4B | +$1.15B | 79 | 4.5% | Increased |
|
| 20 |
UBS AM
Chicago,
Illinois
| $17.9B | +$1.13B | 94 | 3.72% | Increased |
|
| 21 |
Fisher Asset Management
Camas,
Washington
| $17.4B | +$4.9B | 33 | 5.89% | Increased |
|
| 22 |
Capital Research Global Investors
Los Angeles,
California
| $16.9B | +$4.66B | 11 | 2.63% | Increased |
|
| 23 |
Amundi
Paris,
France
| $15.7B | +$3.77B | 35 | 4.27% | Increased |
|
| 24 |
Dimensional Fund Advisors
Austin,
Texas
| $15.4B | -$1.2B | 104 | 3.21% | Reduced |
|
| 25 |
Capital International Investors
Los Angeles,
California
| $15.4B | -$389M | 12 | 3.6% | Reduced |
|